Tilray Brands (TLRY) Asset Writedowns and Impairment (2017 - 2025)
Tilray Brands (TLRY) reported Asset Writedowns and Impairment of $1.4 billion for Q2 2025, up 99.78% quarter-over-quarter from $699.2 million in Q1 2025.
Tilray Brands (TLRY) Asset Writedowns and Impairment (2017 - 2025) Analysis & Trends
Tilray Brands has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $1.4 billion in Q2 2025.
- For the quarter ending Q2 2025, Asset Writedowns and Impairment changed N/A year-over-year to $1.4 billion; the trailing twelve-month figure through Feb 2026 stood at $2.1 billion (up 199.78% YoY), and the FY2025 full-year result was $2.1 billion, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q2 2025 stood at $1.4 billion, up from $699.2 million in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.4 billion in Q2 2025, with the low at $366.2 million in Q2 2022.
- Historically, Asset Writedowns and Impairment has averaged $849.1 million across 3 years, with a median of $816.6 million in 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 1.40 Bn |
| May 31, 2025 | 1.40 Bn |
| Feb 28, 2025 | 699.24 Mn |
| Feb 28, 2025 | 699.24 Mn |
| Feb 28, 2023 | 934.00 Mn |
| Feb 28, 2023 | 934.00 Mn |
| May 31, 2022 | 366.24 Mn |
| May 31, 2022 | 366.24 Mn |
| May 31, 2020 | 14.82 Mn |
| May 31, 2020 | 14.82 Mn |
| Mar 31, 2020 | 46,000.00 |
| Mar 31, 2020 | 46,000.00 |
| Sep 30, 2019 | -275,000.00 |
| Sep 30, 2019 | -275,000.00 |
| Mar 31, 2019 | 536,000.00 |
| Mar 31, 2019 | 536,000.00 |
| Dec 31, 2018 | 268,000.00 |
| Dec 31, 2018 | 268,000.00 |
| Sep 30, 2018 | 795,000.00 |
| Sep 30, 2018 | 795,000.00 |